European Conference on Safe Use of Plant Protection Products
|
|
|
- Maximillian Black
- 10 years ago
- Views:
Transcription
1 European Conference on Safe Use of Plant Protection Products Conference Report, 18 June 2014 In June 2014, the Federal Institute for Risk Assessment in Germany (BfR) and the European Commission hosted the European Conference on Safe Use of Plant Protection Products in Berlin, Germany. The expert conference was attended by representatives of the European Commission (Directorate-General for Health and Consumers), the European Food Safety Authority (EFSA), Member States Competent Authorities, the European Crop Protection Association (ECPA) and the Committee of Professional Agricultural Organisations and the General Committee for Agricultural Cooperation in the European Union (COPA-COGECA). Central topics were the new EFSA draft Guidance on the Assessment of Exposure for Operators, Workers, Residents and Bystanders in Risk Assessment of Plant Protection Products and the further harmonisation of derivation of dermal absorption values and allocation of risk mitigation measures. 1 Introduction The European Conference on Safe Use of Plant Protection Products held in Berlin, Germany, was the first conference of its kind to address harmonisation of zonal risk assessment. Issues which are crucial for better harmonisation of the risk assessment with a focus on safe use and in the context of the zonal authorisation of plant protection products (PPP) were discussed among experts from the national competent authorities, European institutions, and stakeholders. Since the implementation of the Regulation (EC) No. 1107/2009 concerning the placing of plant protection products on the market, many questions have been raised within the scope of zonal authorisation and mutual recognition. Both procedures require a high level of harmonisation between the Member States (MS). Hence, further harmonisation of non-dietary exposure models and risk assessment procedures was the overall objective of this conference. In particular, the conference focused on the EFSA draft Guidance on the Assessment of Exposure for Operators, Workers, Residents and Bystanders in Risk Assessment of Plant Protection Products and on further harmonisation of derivation of dermal absorption values and allocation of risk mitigation measures. The main benefits of such a harmonised approach have been identified as: (1) the same level of protection in all MS, (2) the predictability of evaluations by applying the same methodology, (3) the improved confidence in zonal authorisation and (4) more efficient procedures for zonal authorisation. The transparency of data, the traceability of information and the reproducibility and mutual understanding of the outcomes were highlighted during the discussions as key principles of a harmonised risk assessment. It was pointed out that risk assessment is based on a tiered approach starting with worst case assumptions, allowing a subsequent refinement. Scenarios could be more realistic (less "worst case") if suitable and representative data are avail- Seite 1 von 7
2 able. There was a broad consensus that the development of more realistic models is inevitably linked with increasing data availability. 2 Conference Results 2.1 Risk Assessment and Safe Use of PPP in the EU The conference started with a plenary lecture session introducing the regulatory framework of risk assessment and safe use of PPP in the European Union. The presentations were given by European Commission and EFSA. In the first presentation an overview over the legal frame of zonal evaluation and mutual recognition within the European Union according to Regulation (EC) No 1107/2009 was given. The European Commission is dedicated to support the functioning of mutual recognition. New tools for information exchange between the MS of the European Union could be developed if desired by MS. The communication and document sharing tool CIRCA BC is available to all registered CIRCA BC members in the working area of PPP s and residues. The European Commission is supportive with regards to further harmonisation of risk assessment and welcomes the organisation of subsequent conferences. In accordance with Article 31 of Regulation (EC) No 178/2002 EFSA was asked to proceed with the preparation of a Guidance Document on the Pesticide Exposure Assessment for Workers, Operators, Bystanders and Residents. In the second presentation EFSA s activities on non-dietary exposure to PPP s were presented focussing on the new EFSA guidance document. The guidance provides a quality assessment of existing data bases made available to EFSA and gives recommendations for models and default parameters. An outlook was given on the further steps for finalisation of the document. It is expected that the final guidance document will be forwarded to the European Commission in the autumn of this year and noted by the Standing Committee afterwards. Further EFSA projects in this field, namely the field data collection for non-dietary cumulative exposure assessment and the developed database on operator exposure assessment scenarios, were presented as well. Setting up a database for bystanders and residents was discussed as a future perspective. In the concluding discussion on this session, it was pointed out that a common understanding of the tiered approach in the draft of the EFSA guidance document is essential for further harmonisation. It was noted that more guidance in the EFSA document is needed especially for risk refinement (e.g. which scenarios are covered by first tier assessments, the evaluation of additional studies, and the use of risk mitigation measures). There was a broad agreement that the EFSA draft document Guidance on the Assessment of Exposure for Operators, Workers, Residents and Bystanders in Risk Assessment of Plant Protection Products shall be applied by applicants and authorities to further harmonise the zonal risk assessment procedure of PPP. EFSA will offer presentation and training in early 2015 after the adoption of the guidance. It is intended to update the guidance document as soon as possible if new data become available. Seite 2 von 7
3 2.2 Exposure Estimation and Risk Assessment In this plenary lecture session the exposure assessments for the different exposed groups (operator, worker, bystander and resident) were discussed. Presentations were given by HSE, BfR and ECPA. The exposure assessment for bystanders and residents was presented by HSE. Based on the definition of bystander and resident the differences between these groups and operators and workers were highlighted. In the EFSA draft guidance document four exposure pathways (spray drift, vapour, surface deposits, and entry into adjacent treated crops) are now considered for bystanders and residents. With respect to differences in exposure frequency and duration a short-term exposure assessment is proposed for each of these individual pathways for the bystander based on the 95 th percentile of the exposure estimations. Long-term exposure assessment is proposed for each individual exposure pathway for residents based on the 75 th percentile of the exposure estimates. An addition of all four exposure pathways is considered to be realistic for residents only; in this case the mean exposure estimates would be calculated. The Bystander and Resident Exposure Model (BREAM) database for spray drift exposure was presented. Exposure estimation based of these data is one integral part of the risk assessment for bystanders and residents according to the draft EFSA guidance. In the following discussion the participants agreed that the EFSA Guidance is a starting point for further harmonisation of bystander and resident exposure. Ongoing efforts are needed to close the data gap for several pathways and to increase the level of information on realistic worst case exposure scenarios. All experts appreciated the fact that more data for relevant exposure routes will be provided soon within the framework of the BROWSE project (Bystanders, Residents, Operators and WorkerS Exposure models for plant protection products). In addition, European Crop Protection Association (ECPA) will also provide more data related to exposure routes for bystander and residents. The recently finalised Agricultural Operator Exposure Model (AOEM) was presented by the BfR which led the project. The AOEM is based on a statistical evaluation of new operator exposure data, which have not been used in exposure models before. The new operator exposure model is recommended in the draft EFSA guidance as first tier approach for exposure assessments of typical outdoor application scenarios. The database and the development of the model were described in detail in this presentation. Following the same approach as for the AOEM a new greenhouse model is under development which was presented by the BfR. First results of the re-evaluation of the available greenhouse data from the southern greenhouse project were shown. It is the aim to consider the new greenhouse model after finalisation and adoption by the MS in an amended EFSA guidance. The following discussion highlighted that the AOEM is currently the best available database model for operator exposure estimation and is included in the draft EFSA guidance docu- Seite 3 von 7
4 ment. Participants expressed that this draft should be noted by the Standing Committee and the Member States as soon as possible because it will include the first harmonised exposure model for the procedure of zonal evaluation. It was noted that an ad hoc approach can be followed (e.g. other application techniques) when the model does not cover specific scenarios. For taking into account national characteristics, national addenda will be still necessary in the authorisation procedure. Proposals for the exposure assessments of missing application scenarios such as greenhouse applications, seed treatments or post-harvest applications should be implemented in the EFSA guidance document as well. The participants would welcome more guidance in the EFSA document for the allocation of risk mitigation measures (e.g. definition of working clothing vs. certified coveralls). ECPA s view on the draft EFSA guidance document was also presented. Results of exposure estimations for operators, workers, bystanders and residents prior to and according to the new EFSA guidance were compared. In the discussion afterwards, it was pointed out that the conservatism of certain scenarios is related to the limited data availability. With respect to worker transfer coefficient values ECPA signalised their willingness to check the possibility of providing data used by the US Environmental Protection Agency (Office of Pesticide Progams). Regarding worker exposure the EFSA guidance addresses exposure assessments for repeated applications. The consideration of GAP specifications (e.g. re-entry intervals) could be a possibility for a refinement of worker exposure. The experts expressed their wish for more guidance on the allocation of risk mitigation measures for workers as well (e.g. definition of working clothing vs. certified coverall). 2.3 Dermal Absorption The third session dealt with the estimation of values derived from dermal absorption studies, which is an integral part of risk assessment and closely linked to exposure estimations. Presentations were given by BfR and ECPA. This session provided an overview about different databases that include information on dermal absorption studies. First results from these data evaluation were shown. Furthermore, a proposal for a harmonised procedure estimating dermal absorption was presented. The BfR has developed a database in order to evaluate available data, to check the applicability of the new default values and to derive proposals for further harmonisation of the risk assessment. The BfR database comprises information from 1553 experiments with 131 active substances and 231 formulations. Moreover, it includes a large number of dermal absorption studies, of which 379 studies are rat in vivo, 212 studies are rat in vitro and 387 studies are human in vitro. Data from in vitro studies on human skin have been derived from both dermatomed skin and isolated epidermis. The results support the proposed default values (EFSA 2012) of 25 % for concentrates and 75 % for dilutions of pesticide formulations. A refinement of these default values was not intended by BfR. These default values may be used for the risk assessment of PPP s when experimental data have not been submitted. A comparison of the relative permeability of rat skin vs. human skin using the BfR database Seite 4 von 7
5 has proven it s consistency with the current state of knowledge: For the majority of the tests, rat skin had higher permeability than human skin. Moreover, the hypothesis was verified that the dermal absorption rate according to a Triple pack is lower compared to the stand-alone test using human skin in vitro (a Triple pack is the combination of in vivo animal, in vitro animal and in vitro human dermal absorption studies, OECD 2011). For studies on isolated epidermis, 53 experiments with 19 active substances and 19 formulations were analysed. In 81 % of the cases the dermal absorption rates were lower when Triple packs were used. In contrast, 19 % of the experimental data showed a decreased dermal absorption rate when in vitro human skin studies were considered. The database developed by the European Crop Protection Association (ECPA) is based on an initiative evaluating the reliability and possible reduction of default values and opportunities for read-across that were proposed in the EFSA Scientific opinion: Guidance on Dermal Absorption. ECPA s database includes 360 human in vitro skin studies. With regard to default values for the concentrate, ECPA proposes a decrease of default values of liquids (6%) and for solids (2 %). For the dilution an overall reduction to 30% is proposed. Moreover, for the read across approach ECPA proposes that solvent-based data shall be considered as worst case-read across. Dermal absorption values derived from water-based formulations may function as read across for solids. In contrast, the EFSA guidance document states that a read across between formulation types is largely not acceptable. With respect to the pro rata analysis ECPA concluded that dermal absorption does not increase linearly with the dilution, which again is contrary to EFSA s guidance (EFSA 2012). Therefore, ECPA proposes a pro rata correction with a maximum of 5-fold increase or a default value of 30 %. In the last presentation of this session the BfR proposed a procedure for estimating dermal absorption in the risk assessment. In terms of interpretation and use of experimental data BfR recommends the use of in vitro human skin data according to OECD guideline 428 as a starting point for the assessment. If further refinement is necessary the tiered approach is possible using the above mentioned Triple pack analysis. For the estimation BfR recommends the use of the EFSA Scientific opinion: Guidance on Dermal Absorption (EFSA 2012) to further improve the harmonised procedure. Regarding the pro rata analysis, BfR will perform additional analyses of its database. In the absence of product-specific data BfR recommends three options for the estimation of dermal absorption in the following order: (1) default values are used for the estimation, (2) the one-to-one transfer of experimental data from dermal absorption studies to a similar formulation with the identical active substance may be used. Regarding the similarity of a formulation, BfR recommends to strictly follow the criteria stated by EFSA (EFSA 2012), and (3) the many-to-one approach is envisaged as described in the OECD guidance (OECD 2011). This approach includes the rough estimation of dermal absorption values derived from experimental data of different compounds from the same chemical class or group. For the estimation of dermal absorption values, BfR would not support consideration of oral absorption and oral or dermal toxicological studies with the active substance since in these Seite 5 von 7
6 studies only the active substance was tested and not the possible effects of e.g. coformulants. The following plenary discussion addressed the different goals and outcomes of the databases of the BfR and ECPA. Importantly, it was clarified that these databases were established with different aims and therefore complement each other. The focus of the BfR was the evaluation of available data whereas ECPA s intention was the refinement of already existing values. The experts then explained the differences of the data sets in more detail. BfR included all available data from in vitro human skin studies in the database (e.g. isolated epidermis and dermatomed skin, up to 24 hours of exposure) while on the other hand a restricted scope of selection criteria is characteristic for ECPA s data sets (e.g. only dermatomed skin, 6-10 hours of exposure). The participants agreed that further evaluation of existing data is needed to proceed with the harmonisation in the derivation of dermal absorption. It was proposed that clearly defined evaluation rules and a similar evaluation of both databases would benefit the process of harmonisation. In addition, further guidance for a harmonised procedure for estimating the dermal absorption shall be implemented. At first, exchange of experience between experts from the MS will be required in regard of the harmonisation of single study evaluation results. The results of this exchange will be included in the already existing and updated EFSA document Scientific opinion: Guidance on Dermal Absorption. 2.4 Allocation of Risk Mitigation Measures In the last plenary lecture session the Member State s perspectives regarding risk mitigation measures (RMM) were presented and discussed. In this framework the perspectives from France (ANSES), United Kingdom (HSE) and Germany (BfR) were presented. In France recommendations for personal protective equipment (PPE) are provided by the applicant and have to be verified by the agency in order to advise authorities. Such proposals for PPE or working clothes are based on hazard identification and risk assessment. Working coveralls are used in most cases if they are effective for intended uses. However, these coveralls are currently not regarded as PPE, and certified PPE is needed for specific uses. It was mentioned, that ISO could be applied for the certification of working coveralls to harmonise the requirements. Also in the United Kingdom the PPE recommendations are based on hazard identification and risk assessment. Operators are assumed to wear coveralls as standard working clothes. No PPE is assumed for amateur use. Outdoor workers are generally assumed to have arms, body and legs covered, but for indoor workers minimal protection is assumed. Gloves are not currently considered for worker risk mitigation, but this will change provided employers agree to necessary measures like training including risk awareness, safety signs and regular checks. Risk mitigation measures are limited for bystanders and residents. In Germany PPE recommendations are based on hazard identification and risk assessment as stated by the other MS before. The assessment of operators (certified PPE recommenda- Seite 6 von 7
7 tions according to the Directive Personal protective equipment for handling plant protection products, 2006), workers (RMM, e.g. PPE, re-entry restriction), bystander and residents (allocation of RMM, e.g. drift reducing nozzles, safety distances) were summarised. Within the following plenary discussion the need for a consistent definition, mutual understanding and allocation of general RMM (e.g. certified gloves and coveralls, working clothes) became clear. To further improve harmonisation, sharing of information and training as well as voluntary stewardship (e.g. consider lack of compliance for workers) are essential. Moreover, the allocation of safety distances for bystander and residents and the consistency of common approaches (e.g. certain PPE for specific exposure groups, assessment of specific uses home and garden uses, assessment of public areas) are topics requiring further harmonisation. 3 Conclusions According to the experts, holding a first conference on topics of harmonisation of zonal nondietary risk assessment was long-awaited. It is an important step towards information exchange and improvement of harmonisation of the safe use of plant protection products. There was consensus among the participants that the EFSA draft Guidance on the Assessment of Exposure for Operators, Workers, Residents and Bystanders in Risk Assessment of Plant Protection Products is a major step towards harmonised risk assessment. The guidance should become mandatory for first tier assessments in the zonal authorisation procedure for applicants and should be the basis for the risk assessment of the Member States Competent Authorities. It was suggested, that further development of an amended EFSA guidance is essential and missing scenarios such as greenhouse applications have to be implemented as soon as possible. With respect to derivation of dermal absorption there is a great interest among all participants in ongoing harmonisation of the procedure. To further develop current assessment approaches, actual results from dermal absorption studies will also be taken into account. The participants agreed that further evaluation of existing data is needed to proceed with the harmonisation in the derivation of dermal absorption. All experts agreed that there is a high need in harmonisation regarding the consistency of definition, mutual understanding and allocation of general risk mitigation measures. Lastly, it became clear that the participants would greatly welcome subsequent meetings in order to share experiences and discuss new and updated information. This is also important for other fields of risk assessment relevant for zonal authorisation. The presentations given in the plenary session are also available in full on the BfR website: oducts html Seite 7 von 7
Frequently asked questions on the procedure for the re-assessment of glyphosate within the framework of the EU active substance review
Frequently asked questions on the procedure for the re-assessment of glyphosate within the framework of the EU active substance review BfR FAQ, 12 November 2015 Active substances used in pesticides are
New EU pesticide legislation the view of a manufacturer
Aspects of Applied Biology 106, 2011 Crop Protection in Southern Britain New EU pesticide legislation the view of a manufacturer By J C WILLIAMS Bayer CropScience Ltd, 230, Cambridge Science Park, Milton
GUIDANCE DOCUMENT ON THE EVALUATION OF NEW ACTIVE SUBSTANCE DATA POST APPROVAL
1 EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL Directorate E Safety of the food chain Unit E.3 - Chemicals, contaminants, pesticides SANCO/10328/2004 rev 8 24.01.2012 GUIDANCE DOCUMENT
Marketing Authorisation Of A Product In Czech Republic
MARKETING AUTHORISATION APPLICATION FOR NEW PLANT PROTECTION PRODUCTS VIA THE MUTUAL RECOGNITION PROCEDURE AS SPECIFIED UNDER REGULATION (EC) No 1107/2009 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL
Amidosulfuron SANCO/1101/08 rev. 1 20 January 2008. EU Limited
EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL Directorate E Safety of the food chain Unit E.3 - Chemicals, contaminants, pesticides Amidosulfuron SANCO/1101/08 rev. 1 20 January
Resources Based, Manufacturing and Consumer Goods Industries Chemicals Industry
EUROPEAN COMMISSION Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs Resources Based, Manufacturing and Consumer Goods Industries Chemicals Industry Version March 2015 QUESTIONS
2,2,2 trifluoroethanol
GPS Safety Summary 2,2,2 trifluoroethanol Chemical Identity Brand names 2,2,2 trifluoroethanol CAS number 75 89 8 Chemical name (IUPAC) 2,2,2 trifluoroethanol Molecular formula CF 3 CH 2 OH Synonyms TFE;
Chemical safety and big data: the industry s demands
Chemical safety and big data: the industry s demands Richard CURRIE Senior Technical Expert; Group Leader & Global Predictive and Computational Toxicology Lead Valid results Useful results Credit Money/Grants
Submission of scientific peer-reviewed open literature for the approval of pesticide active substances under Regulation (EC) No 1107/2009 1, 2
GUIDANCE OF EFSA - DRAFT Submission of scientific peer-reviewed open literature for the approval of pesticide active substances under Regulation (EC) No 1107/2009 1, 2 ABSTRACT European Food Safety Authority
Compilation of individual product-specific guidance on demonstration of bioequivalence
17 December 2014 EMA/CHMP/736403/2014 Committee for Medicinal Products for Human Use (CHMP) Compilation of individual product-specific guidance on demonstration of bioequivalence Initial batch of individual
Experiencing REACH Exposure Assessments
Experiencing REACH Exposure Assessments By Debbie Lander, Ph.D. E. I. Du Pont de Nemours and Company EPA Computational Toxicology Communities of Practice January 27, 2011 2 Exposure Assessments under REACH
Targeted Risk Assessment Addendum to the User Guide for the Standalone Consumer Tool Version 3.1 -
Targeted Risk Assessment Addendum to the User Guide for the Standalone Consumer Tool Version 3.1 - June 2014 EUROPEAN CENTRE FOR ECOTOXICOLOGY AND TOXICOLOGY OF CHEMICALS www.ecetoc.org Contents ADDENDUM
Joint development of a new Agricultural Operator Exposure Model
Bundesinstitut für Risikobewertung Joint development of a new Agricultural Operator Exposure Model Project Report Federal Institute for Risk Assessment (BfR) 1) Health and Safety Executive (HSE) 2) French
ROADMAP. A. Context and problem definition
ROADMAP TITLE OF THE INITIATIVE Defining criteria for identifying Endocrine Disruptors in the context of the implementation of the Plant Protection Product Regulation and Biocidal Products Regulation LEAD
EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY COMMISSION STAFF WORKING DOCUMENT 1
EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Safety of the Food Chain Pesticides and Biocides COMMISSION STAFF WORKING DOCUMENT 1 Basic Substance Calcium hydroxide SANCO/10148/2015
UK experience of the Renewable Transport Fuel Obligation (RTFO) and policies to promote the development of waste-derived and advanced biofuels
UK experience of the Renewable Transport Fuel Obligation (RTFO) and policies to promote the development of waste-derived and advanced biofuels European Biofuels Technology Platform 6 th Stakeholder Plenary
ECHA s REACH 2018 Roadmap
ECHA s REACH 2018 Roadmap Progress Report January 2016 Disclaimer This publication is solely intended for information purposes and does not necessarily represent the official opinion of the European Chemicals
COMMISSION IMPLEMENTING DECISION
20.3.2014 Official Journal of the European Union L 82/29 COMMISSION IMPLEMENTING DECISION of 18 March 2014 on the organisation of a temporary experiment providing for certain derogations for the marketing
- A9/1 - Format for the listing of end points to be included in the Tier III overall summary and assessments
- A9/1 - - A9/1 - APPENDIX 9 FORMAT FOR THE LISTING OF END POINTS TO BE INCLUDED IN THE REASONED STATEMENT OF THE OVERALL CONCLUSIONS DRAWN BY THE REGULATORY AUTHORITY (LEVEL 2)8 General remark: Testing
Europe s Application Monitoring and Equipment Verification
The 8th Annual Pesticide Stewardship Conference Asheville, North Carolina Europe s Application Monitoring and Equipment Verification Dirk Rautmann Julius Kühn-Institute Federal Research Institute for Cultivated
Chapter 12: SPECIFIC TARGET ORGAN SYSTEMIC TOXICITY (TOST) FOLLOWING A SINGLE EXPOSURE
Chapter 12: SPECIFIC TARGET ORGAN SYSTEMIC TOXICITY (TOST) FOLLOWING A SINGLE EXPOSURE DEFINITIONS 1. Classification identifies the chemical substance as being a specific target organ/systemic toxicant
Risk-Based Decision Making for Site Cleanup
July 2013 Risk-Based Decision Making for Site Cleanup The Oklahoma Department of Environmental Quality (DEQ) has adopted a risk based decision making process to provide a framework for determining cleanup
Environmental Monitoring
Environmental Monitoring For the import of oilseed rape from event T45 (ACS-BNØØ8-2) for food, feed and industrial uses 1. Introduction Authorisation holders have the obligation to implement, if appropriate,
PRODUCT ID: LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION
SECTION 15: REGULATORY INFORMATION This product has been classified in accordance with the hazard criteria of the Controlled Products Regulations and the MSDS contains all the information required by the
EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL. Directorate E - Safety of the food chain E3 - Chemicals, contaminants, pesticides
EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL Directorate E - Safety of the food chain E3 - Chemicals, contaminants, pesticides SANCO/5272/2009 rev. 3 28 October 2010 1 Guidance Document on
Waste Transfer Pricing Methodology for the disposal of higher activity waste from new nuclear power stations
Waste Transfer Pricing Methodology for the disposal of higher activity waste from new nuclear power stations December 2011 Contents Contents... i Introduction... 1 Executive Summary... 1 Background...
Nano-Titanium Dioxide in Sunscreens. Gerald Renner, Colipa
Nano-Titanium Dioxide in Sunscreens Gerald Renner, Colipa Cosmetic Use of Nanomaterials In 2008, a survey of nanomaterials sold in EU cosmetic products amongst member companies of Colipa and national trade
JAN 2 7 2016. outdoor commercial agricultural operations in Hawaii has. been increasing. Unlike the majority of Hawaii's farmers, these
THE SENATE TWENTY-EIGHTH LEGISLATURE, 0 STATE OF HAWAII JAN 0 A BILL FOR AN ACT S.B. NO. mb RELATING TO ENVIRONMENTAL PROTECTION. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII: SECTION. The legislature
Aliphatic Alcohols Facts
United States Prevention, Pesticides EPA 738-F-07-004 Environmental Protection and Toxic Substances June 2007 Agency (7508P) Aliphatic Alcohols Facts Pesticide Registration All pesticides sold or distributed
Diverse proposals exist to include micro organisms in the group of so called biostimulants.
Minutes of the The 6th International Symposium Plant Protection and Plant Health in Europe Micro organisms as agents between fertilization and plant protection 13 14 May 2014 Braunschweig, Germany The
Annex. DRAFT Guidance Document on the Planning and Implementation of Joint Reviews of Pesticides. Revision 8 September 2010
Annex DRAFT Guidance Document on the Planning and Implementation of Joint Reviews of Pesticides Revision 8 September 2010 Table of Contents SECTION 1 BACKGROUND AND OVERVIEW OF THE JOINT REVIEW PROCESS...
Dress for Success! Some Things to Know About Personal Protective Equipment BEFORE You Handle a Pesticide
Dress for Success! Some Things to Know About Personal Protective Equipment BEFORE You Handle a Pesticide Always read and follow label directions before buying or using a pesticide. Follow all appropriate
Environmental protection under TTIP
position // march 2015 Environmental protection under TTIP For our environment Imprint Publisher: Federal Environment Agency Division I 1.4 PO Box 14 06 D-06844 Dessau-Roßlau Tel: +49 340-2103-0 [email protected]
The Biocidal Products Regulation. Latest developments
The Biocidal Products Regulation Latest developments Eleventh Antimicrobial Workshop March 10-11, 2015 Hyatt Regency Crystal City Arlington, VA Pierre Choraine European Commission DG SANTE, Unit E.3 ECHA
September 19, 1984 FOOD PRODUCTION AND DIRECTION GÉNÉRALE, SECTION INSPECTION BRANCH PRODUCTION ET INSPECTION PESTICIDES DES ALIMENTS TRADE MEMORANDUM
Agriculture Canada September 19, 1984 T-1-245 FOOD PRODUCTION AND DIRECTION GÉNÉRALE, SECTION INSPECTION BRANCH PRODUCTION ET INSPECTION PESTICIDES DES ALIMENTS TRADE MEMORANDUM RE: Guidelines for Developing
Measurement of Banks Exposure to Interest Rate Risk and Principles for the Management of Interest Rate Risk respectively.
INTEREST RATE RISK IN THE BANKING BOOK Over the past decade the Basel Committee on Banking Supervision (the Basel Committee) has released a number of consultative documents discussing the management and
Guidance on selected default values to be used by the EFSA Scientific Committee, Scientific Panels and Units in the absence of actual measured data 1
EFSA Journal 2012;10(3):2579 SCIENTIFIC OPINION Guidance on selected default values to be used by the EFSA Scientific Committee, Scientific Panels and Units in the absence of actual measured data 1 ABSTRACT
System Basics for the certification of sustainable biomass and bioenergy
ISCC 201 System Basics System Basics for the certification of sustainable biomass and bioenergy ISCC 10-04-19 V 1.15 10-04-19 Copyright notice ISCC 2010 This ISCC document is protected by copyright. It
An illustrative example of the exposure scenarios to be annexed to the safety data sheet. Part 2: Example
An illustrative example of the exposure scenarios to be annexed to the safety data sheet Part 2: Example An illustrative example of the exposure scenarios to be annexed to the safety data sheet Part 2:
Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice
Version 8 (final) EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 S\common\legal-legislation\75-319nd81-851\91-356\eudralexvol4\Annex
Proposal for a RECOMMENDATION OF THE EUROPEAN COMMISSION
EUROPEAN COMMISSION Brussels, XXX [ ] (2013) XXX draft Proposal for a RECOMMENDATION OF THE EUROPEAN COMMISSION Providing minimum principles for the exploration and production of hydrocarbons (especially
Definitions and Interpretations of Skin Notations and the Use of Biological Monitoring to Assess Total Exposure
Definitions and Interpretations of Skin Notations and the Use of Biological Monitoring to Assess Total Exposure LARRY K. LOWRY, Ph. D. University of Texas Health Center at Tyler Chair, ACGIH BEI Committee
Risk Assessment Report on (3-CHLORO-2-HYDROXYPROPYL)TRIMETHYLAMMONIUM CHLORIDE (CHPTAC)
Scientific Committee on Health and Environmental Risks SCHER Risk Assessment Report on (3-CHLORO-2-HYDROXYPROPYL)TRIMETHYLAMMONIUM CHLORIDE (CHPTAC) Human Health Part CAS No.: 3327-22-8 EINECS No.: 222-048-3
RADIOPHARMACEUTICALS BASED ON MONOCLONAL ANTIBODIES
RADIOPHARMACEUTICALS BASED ON MONOCLONAL ANTIBODIES Guideline Title Radiopharmaceuticals based on Monoclonal Antibodies Legislative basis Directives 65/65/EEC, 75/318/EEC as amended, Directive 89/343/EEC
Registration Decision. Sulfoxaflor
Registration Decision RD2015-09 Sulfoxaflor (publié aussi en français) 8 June 2015 This document is published by the Health Canada Pest Management Regulatory Agency. For further information, please contact:
EU ECOLABEL FOR ABSORBENT HYGIENE PRODUCTS
EU ECOLABEL FOR ABSORBENT HYGIENE PRODUCTS BEUC and EEB position on proposal to be voted on 14 th of March 2014 Contact: Blanca Morales [email protected] & [email protected] Ref.: X/2014/014-05/03/2014
REACH Understanding the Risk Assessment Process
_experience the commitment TM REACH Understanding the Risk Assessment Process Introduction Across virtually every segment of society, we witness how chemicals have delivered significant benefits to society.
Occupational/Industrial Hygiene Knowledge and Competency Requirements
Occupational/Industrial Hygiene Knowledge and Competency Requirements I. PREFACE The International Occupational Hygiene Association's (IOHA's) National Accreditation Recognition (NAR) Committee holds a
Committee for Risk Assessment RAC. Opinion proposing harmonised classification and labelling at EU level of ethylbenzene
Committee for Risk Assessment RAC Opinion proposing harmonised classification and labelling at EU level of ethylbenzene EC number: 202-849-4 CAS number: 100-41-4 ECHA/RAC/CLH-O-0000001542-81-03/F. Adopted
Guidance document for the classification of dangerous goods with regard to their "corrosive effect on living tissue"
Guidance document for the classification of dangerous goods with regard to their "corrosive effect on living tissue" Updated guidance document of the BfR published on 12 June 2012 This guidance document
Results of the public consultation on the TOP10 most burdensome legislative acts for SMEs
Results of the public consultation on the TOP10 most burdensome legislative acts for SMEs 1. Introduction The public consultation on the TOP10 most burdensome legislative acts for SMEs ("TOP10 public consultation")
GPS Safety Summary DIPROPYLENE GLYCOL DIACRYLATE
GPS Safety Summary Substance Name: DIPROPYLENE GLYCOL DIACRYLATE 1. General Statement DPGDA is a difunctional acrylate monomer which can be polymerised by free radicals. In particular, DPGDA is designed
SAFETY DATA SHEET Sorex Wasp Nest Destroyer MK II
01. PRODUCT AND COMPANY IDENTIFICATION Trade Name Product Code Intended Use INSE96001a Approved under The Control of Pesticides Regulations 1986 (as amended) for the control and destructions of the nests
Methods verification. Transfer of validated methods into laboratories working routine. Dr. Manuela Schulze 1
Methods verification Transfer of validated methods into laboratories working routine Dr. Manuela Schulze 1 1. Introduction 2. Definitions and differences validation verification 3. How to perform verification
MATERIAL SAFETY DATA SHEET
Page 1 of 5 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
OUR CUSTOMERS. Exciting, beautifully designed, excellent quality clothing and homeware that reflects the aspirations and means of our customers
OUR CUSTOMERS Content Our Approach Our aim is to meet or exceed our customers expectations of Next as a company and the products we sell by providing: Exciting, beautifully designed, excellent quality
Hydroquinone. Chemical Identity. Applications. Safety Assessment, Exposure and Risk Management Recommendations
GPS Safety Summary Contacts Hydroquinone Chemical Identity Brand names Hydroquinone CAS number 123-31-9 Chemical name (IUPAC) benzene-1,4-diol Molecular formula C 6H 6O 2 Synonyms Para-hydroxyphenol; 1,4-dihydroxybenzol;
International Accounting Standard 32 Financial Instruments: Presentation
EC staff consolidated version as of 21 June 2012, EN EU IAS 32 FOR INFORMATION PURPOSES ONLY International Accounting Standard 32 Financial Instruments: Presentation Objective 1 [Deleted] 2 The objective
THE APPLICATION OF A VALUE ASSURANCE SYSTEM TO OIL & GAS DEVELOPMENT PROJECTS (Guido Mattu, Franca Marini)
PAGE 1 THE APPLICATION OF A VALUE ASSURANCE SYSTEM TO OIL & GAS DEVELOPMENT PROJECTS (Guido Mattu, Franca Marini) Ing. Guido Mattu More than 25 years experience in Engineering and Project Management activities
Title: OHS Risk Management Procedure
Issue Date: July 2011 Review Date: July 2013 Page Number: 1 of 9 1. Purpose: To outline the methodology by which Department of Education and Early Childhood Development (DEECD) identifies, assesses, controls
June 2010 HEALTH, SAFETY, AND ENVIRONMENT MANAGEMENT SYSTEM (HSEMS)
June 2010 HEALTH, SAFETY, AND ENVIRONMENT MANAGEMENT SYSTEM (HSEMS) TABLE OF CONTENTS PAGE PART I INTRODUCTION Corporate Health, Safety and Environment Policy.. 1 Purpose... 2 HSEMS Framework... 3 PART
About Pure Earth and the Toxic Site Identification Program
About and the Toxic Site Identification Program is a New York based not-for-profit organization that partners with governments, NGOs and community groups to solve life-threatening pollution problems in
AERIAL PLANT PROTECTION WORK IN AGRICULTURE IN HUNGARY (Sent to OECD as national proposal to make best practice for pesticide aerial application)
AERIAL PLANT PROTECTION WORK IN AGRICULTURE IN HUNGARY (Sent to OECD as national proposal to make best practice for pesticide aerial application) I. Historical background In Hungary, aerial application
GPS Safety Summary. Substance Name: ETHOXYLATED TRIMETHYLOLPROPANE TRIACRYLATE
GPS Safety Summary Substance Name: ETHOXYLATED TRIMETHYLOLPROPANE TRIACRYLATE 1. General Statement SR 454 is a trifunctional low viscosity acrylate monomer for use in ultra violet and electron beam curing
NAFTA TWG Sound Science and Policy
NAFTA TWG Sound Science and Policy Presentation to the NAFTA Technical Working Group on Pesticides Stakeholder-Government Meeting November 17, 2011 Dr. Peter Chan, Director General Health Evaluation Directorate
Feasibility Study for a EU Pension Fund for Researchers. European Commission Research Directorate-General
Feasibility Study for a EU Pension Fund for Researchers European Commission Research Directorate-General Executive Summary n RTD/DirC/C4/2009/026879 1 Executive Summary This report covers the main results
Authorisation and Restriction Newsletter
Authorisation and Restriction Newsletter August 2010, N 1 The information contained in this document is intended for guidance only and whilst the information is provided in utmost good faith and has been
The Management of Pharmaceuticals in the Environment (PIE) FAQ. Key questions and answers. Q: How do pharmaceuticals get into the environment?
The Management of Pharmaceuticals in the Environment (PIE) FAQ Key questions and answers Q: How do pharmaceuticals get into the environment? A: Like many foods and supplements that are consumed by humans
Adipic acid. GPS Safety Summary. Chemical Identity. Applications. Safety Assessment, Exposure and Risk Management Recommendations
GPS Safety Summary Chemical Identity Adipic acid Brand names Rhodiacid AA - Adipic acid CAS number 124-04-9 Chemical name (IUPAC) Hexanedioic acid Molecular formula C 6 H 10 O 4 Synonyms 1,6-Hexanedioic
DISCUSSION NON-PAPER. How to put ideas for cooperation under TTIP into practice a few examples
1 DISCUSSION NON-PAPER How to put ideas for cooperation under TTIP into practice a few examples Introductory Note: This paper provides descriptions of various processes under REACH and CLP, and is destined
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE S1A. Current Step 4 version
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE GUIDELINE ON THE NEED FOR CARCINOGENICITY STUDIES
Questions & answers on signal management
23 October 2015 EMA/261758/2013 Inspections and Human Medicines Pharmacovigilance Division This document addresses a number of questions which stakeholders, in particular marketing authorisation holders
TESTIMONY OF DR. STEVEN BRADBURY DIRECTOR, OFFICE OF PESTICIDE PROGRAMS U.S. ENVIRONMENTAL PROTECTION AGENCY
TESTIMONY OF DR. STEVEN BRADBURY DIRECTOR, OFFICE OF PESTICIDE PROGRAMS U.S. ENVIRONMENTAL PROTECTION AGENCY BEFORE THE SUBCOMMITTEE ON NUTRITION AND HORTICULTURE OF THE AGRICULTURE COMMITTEE AND SUBCOMMITTEE
PRODUCT SAFETY DATA SHEET According to 91/155 EC 1. IDENTIFICATION OF THE SUBSTANCE / PREPARATION AND OF THE COMPANY / UNDERTAKING
G.W.B.PRODUCT LTD, 276 YORK WAY, LONDON N79PH TEL:020 7619 1650 FAX:020 7609 9196 EMAIL:[email protected] www.gwbproducts.co.uk -1-1. IDENTIFICATION OF THE SUBSTANCE / PREPARATION AND OF THE COMPANY /
HEALTH, SAFETY, ENVIRONMENT AND COMMUNITY MANAGEMENT STANDARDS. OCTOBER 2011- ISSUE No 01. Doc No: HSEC MS 001
HEALTH, SAFETY, ENVIRONMENT AND COMMUNITY MANAGEMENT S OCTOBER 2011- ISSUE No 01 Doc No: MS 001 Introduction Celtique Energie is in the business of exploring for oil and gas in proven basins in Europe.
European Market Infrastructure Regulation (EMIR): Pension fund exemption on central clearing
European Market Infrastructure Regulation (EMIR): Pension fund exemption on central clearing Finding a solution for cash variation margin remains the main concern Executive Summary The fundamental issue
System Basics for the certification of sustainable biomass and bioenergy
ISCC 201 System Basics System Basics for the certification of sustainable biomass and bioenergy ISCC 11-03-15 V 2.3-EU Copyright notice ISCC 2011 This ISCC document is protected by copyright. It is freely
Sustainability in Global Supply Chains Information and Guidance for Companies
Sustainability in Global Supply Chains Information and Guidance for Companies econsense Discussion Paper Publisher/Editor: econsense Forum for Sustainable Development of German Business Oberwallstraße
Regulatory approval routes in the European System for Medicinal Products
Regulatory approval routes in the European System for Medicinal Products Cardiovascular Combination Pharmacotherapy Global Summit, Melbourne, 8 th May 2014 Presented by: Kevin Blake Human Medicines Research
